Skip Nav Destination
Issues
1 March 2015
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Topics:
autoimmunity
,
diabetes mellitus, type 1
,
insulin
,
obesity
,
primary health care
Diabetes Care February 2015, Vol.38, 341-342. doi:https://doi.org/10.2337/dc15-ti03
Commentary
Responding to the Challenges of Primary Diabetes Care Through the National Diabetes Education Program
Topics:
comorbidity
,
delivery of health care
,
depressive disorders
,
health personnel
,
patient care team
Diabetes Care February 2015, Vol.38, 343-344. doi:https://doi.org/10.2337/dc14-1922
Gestational Diabetes Mellitus and the Offspring—Jack and Jill Are Different Still
Topics:
gestational diabetes
,
hyperglycemia
,
obesity
,
child
,
childhood obesity
Diabetes Care February 2015, Vol.38, 345-346. doi:https://doi.org/10.2337/dc14-2874
Profiles in Progress
Saul Genuth, MD: Clinical Researcher and Leader in Developing Modern Diabetes Treatment
Topics:
dcct trial
,
diabetes mellitus, type 1
,
diabetes mellitus, type 2
,
edic trial
,
obesity
Diabetes Care February 2015, Vol.38, 347-351. doi:https://doi.org/10.2337/dc14-1396
Evolving Tactics With Inhibition of Sodium–Glucose Cotransporters
SGLT2 Inhibitors: The Latest “New Kids on the Block”!
Topics:
child
,
sodium-glucose transporter 2 inhibitors
,
diabetes mellitus, type 2
,
glycemic control
,
glucose
Diabetes Care February 2015, Vol.38, 352-354. doi:https://doi.org/10.2337/dc14-3048
Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
Lawrence A. Leiter; Kun-Ho Yoon; Pablo Arias; Gisle Langslet; John Xie; Dainius A. Balis; Dawn Millington; Frank Vercruysse; William Canovatchel; Gary Meininger
Topics:
canagliflozin
,
diabetes mellitus, type 2
,
glimepiride
,
metformin
,
weight reduction
Diabetes Care September 2014, Vol.38, 355-364. doi:https://doi.org/10.2337/dc13-2762
Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial
Stephan Matthaei; Keith Bowering; Katja Rohwedder; Anke Grohl; Shamik Parikh; for the Study 05 Group
Topics:
dapagliflozin
,
glycemic control
,
hemoglobin a, glycosylated
,
metformin
,
sulfonylurea compounds
Diabetes Care January 2015, Vol.38, 365-372. doi:https://doi.org/10.2337/dc14-0666
Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?
Topics:
combined modality therapy
,
diabetes mellitus, type 2
,
dipeptidyl-peptidase iv inhibitors
,
sodium-glucose transporter 2 inhibitors
,
hemoglobin a, glycosylated
Diabetes Care February 2015, Vol.38, 373-375. doi:https://doi.org/10.2337/dc14-2517
Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
Topics:
dapagliflozin
,
diabetes mellitus, type 2
,
hemoglobin a, glycosylated
,
metformin
,
saxagliptin
Diabetes Care October 2014, Vol.38, 376-383. doi:https://doi.org/10.2337/dc14-1142
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Ralph A. DeFronzo; Andrew Lewin; Sanjay Patel; Dacheng Liu; Renee Kaste; Hans J. Woerle; Uli C. Broedl
Topics:
diabetes mellitus, type 2
,
empagliflozin
,
hemoglobin a, glycosylated
,
linagliptin
,
metformin
Diabetes Care January 2015, Vol.38, 384-393. doi:https://doi.org/10.2337/dc14-2364
Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes
Andrew Lewin; Ralph A. DeFronzo; Sanjay Patel; Dacheng Liu; Renee Kaste; Hans J. Woerle; Uli C. Broedl
Diabetes Care January 2015, Vol.38, 394-402. doi:https://doi.org/10.2337/dc14-2365
Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes
Bruce Neal; Vlado Perkovic; Dick de Zeeuw; Kenneth W. Mahaffey; Greg Fulcher; Kirk Ways; Mehul Desai; Wayne Shaw; George Capuano; Maria Alba; Joel Jiang; Frank Vercruysse; Gary Meininger; David Matthews; on behalf of the CANVAS Trial Collaborative Group
Topics:
canagliflozin
,
insulin
,
hemoglobin a, glycosylated
,
glucose
,
diabetes mellitus, type 2
Diabetes Care December 2014, Vol.38, 403-411. doi:https://doi.org/10.2337/dc14-1237
Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
Robert R. Henry; Julio Rosenstock; Steven Edelman; Sunder Mudaliar; Alexandros-Georgios Chalamandaris; Sreeneeranj Kasichayanula; Allyson Bogle; Nayyar Iqbal; James List; Steven C. Griffen
Topics:
dapagliflozin
,
diabetes mellitus, type 1
,
insulin
,
glucose
,
pharmacodynamics
Diabetes Care September 2014, Vol.38, 412-419. doi:https://doi.org/10.2337/dc13-2955
Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
Ilkka Tikkanen; Kirsi Narko; Cordula Zeller; Alexandra Green; Afshin Salsali; Uli C. Broedl; Hans J. Woerle; on behalf of the EMPA-REG BP Investigators
Topics:
ambulatory blood pressure monitoring
,
diabetes mellitus, type 2
,
empagliflozin
,
hypertension
,
hemoglobin a, glycosylated
Diabetes Care September 2014, Vol.38, 420-428. doi:https://doi.org/10.2337/dc14-1096
Blood Pressure Reduction: An Added Benefit of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
Topics:
blood pressure
,
diabetes mellitus, type 2
,
sodium-glucose transporter 2 inhibitors
,
hypertension
Diabetes Care February 2015, Vol.38, 429-430. doi:https://doi.org/10.2337/dc14-1596
Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Patients With Type 2 Diabetes on Metformin Monotherapy
Julio Rosenstock; William T. Cefalu; Pablo Lapuerta; Brian Zambrowicz; Ike Ogbaa; Phillip Banks; Arthur Sands
Topics:
diabetes mellitus, type 2
,
sotagliflozin
,
glycosuria
,
metformin
Diabetes Care September 2014, Vol.38, 431-438. doi:https://doi.org/10.2337/dc14-0890
Clinical Care / Education / Nutrition / Psychosocial Research
PCSK7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: The POUNDS LOST Trial
Topics:
diet
,
genotype
,
insulin
,
insulin resistance
,
reducing diet
Diabetes Care December 2014, Vol.38, 439-444. doi:https://doi.org/10.2337/dc14-0473
Mild Gestational Diabetes Mellitus and Long-Term Child Health
Mark B. Landon; Madeline Murguia Rice; Michael W. Varner; Brian M. Casey; Uma M. Reddy; Ronald J. Wapner; Dwight J. Rouse; Joseph R. Biggio, Jr.; John M. Thorp; Edward K. Chien; George Saade; Alan M. Peaceman; Sean C. Blackwell; J. Peter VanDorsten; for the
Topics:
body mass index procedure
,
child
,
childhood obesity
,
follow-up
,
gestational diabetes
Diabetes Care November 2014, Vol.38, 445-452. doi:https://doi.org/10.2337/dc14-2159
Risks of Psychiatric Disorders and Suicide Attempts in Children and Adolescents With Type 1 Diabetes: A Population-Based Cohort Study
Topics:
diabetes mellitus, type 1
,
mental disorders
,
child
Diabetes Care February 2015, Vol.38, 453-459. doi:https://doi.org/10.2337/dc14-0262
Epidemiology / Health Services Research
Life Years Lost and Lifetime Health Care Expenditures Associated With Diabetes in the U.S., National Health Interview Survey, 1997–2000
Topics:
body mass index procedure
,
national health interview survey
,
obesity
,
overweight
,
follow-up
Diabetes Care December 2014, Vol.38, 460-468. doi:https://doi.org/10.2337/dc14-1453
How Do People With Diabetes Describe Their Experiences in Primary Care? Evidence From 85,760 Patients With Self-reported Diabetes From the English General Practice Patient Survey
Charlotte A.M. Paddison; Catherine L. Saunders; Gary A. Abel; Rupert A. Payne; Amanda I. Adler; Jonathan P. Graffy; Martin O. Roland
Topics:
primary health care
,
self-report
,
comorbidity
Diabetes Care September 2014, Vol.38, 469-475. doi:https://doi.org/10.2337/dc14-1095
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
Asa K. Davis; Stephanie N. DuBose; Michael J. Haller; Kellee M. Miller; Linda A. DiMeglio; Kathleen E. Bethin; Robin S. Goland; Ellen M. Greenberg; David R. Liljenquist; Andrew J. Ahmann; Santica M. Marcovina; Anne L. Peters; Roy W. Beck; Carla J. Greenbaum; for the T1D Exchange Clinic Network
Topics:
c-peptide
,
diabetes mellitus, type 1
Diabetes Care December 2014, Vol.38, 476-481. doi:https://doi.org/10.2337/dc14-1952
Trends in Diabetes Incidence: The Framingham Heart Study
Topics:
body mass index procedure
,
framingham heart study
,
obesity
,
overweight
,
bariatric surgery
Diabetes Care December 2014, Vol.38, 482-487. doi:https://doi.org/10.2337/dc14-1432
Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals
Graham P. Leese; Irene M. Stratton; Martin Land; Max O. Bachmann; Colin Jones; Peter Scanlon; Helen C. Looker; Brian Ferguson; on behalf of the Four Nations Diabetic Retinopathy Screening Study Group
Topics:
diabetic retinopathy
,
eye diseases
,
retinal diseases
,
screening
,
eye
Diabetes Care December 2014, Vol.38, 488-494. doi:https://doi.org/10.2337/dc14-1778
The Risk of Colorectal Cancer in Patients With Type 2 Diabetes: Associations With Treatment Stage and Obesity
Topics:
colorectal cancer
,
diabetes mellitus, type 2
,
obesity
,
insulin
Diabetes Care December 2014, Vol.38, 495-502. doi:https://doi.org/10.2337/dc14-1175
Emerging Technologies and Therapeutics
Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 Diabetes
Francesca Porcellati; Paola Lucidi; Patrizia Cioli; Paola Candeloro; Anna Marinelli Andreoli; Stefania Marzotti; Maura Ambrogi; Geremia B. Bolli; Carmine G. Fanelli
Topics:
diabetes mellitus, type 2
,
insulin
,
insulin glargine
,
plasma
,
glucose
Diabetes Care December 2014, Vol.38, 503-512. doi:https://doi.org/10.2337/dc14-0649
Pathophysiology / Complications
Tyrosine Phosphatase–Related Islet Antigen 2(256–760) Autoantibodies, the Only Marker of Islet Autoimmunity That Increases by Increasing the Degree of BMI in Obese Subjects With Type 2 Diabetes
Raffaella Buzzetti; Marialuisa Spoletini; Simona Zampetti; Giuseppe Campagna; Lidia Marandola; Francesca Panimolle; Francesco Dotta; Claudio Tiberti; for the NIRAD Study Group (NIRAD 8)
Topics:
antibodies
,
antigens
,
autoantibodies
,
autoimmunity
,
body mass index procedure
Diabetes Care January 2015, Vol.38, 513-520. doi:https://doi.org/10.2337/dc14-1638
Cardiovascular and Metabolic Risk
Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes
Markus Herrmann; David R. Sullivan; Anne-Sophie Veillard; Thomas McCorquodale; Isabella R. Straub; Russell Scott; Markku Laakso; Duncan Topliss; Alicia J. Jenkins; Stefan Blankenberg; Anthony Burton; Anthony C. Keech; for the FIELD Study Investigators
Topics:
25-hydroxyvitamin d
,
c-reactive protein
,
cyclic amp receptor protein
,
diabetes mellitus, type 2
,
epley maneuver
Diabetes Care December 2014, Vol.38, 521-528. doi:https://doi.org/10.2337/dc14-0180
Meta-analysis
Sleep Duration and Risk of Type 2 Diabetes: A Meta-analysis of Prospective Studies
Zhilei Shan; Hongfei Ma; Manling Xie; Peipei Yan; Yanjun Guo; Wei Bao; Ying Rong; Chandra L. Jackson; Frank B. Hu; Liegang Liu
Topics:
diabetes mellitus, type 2
,
sleep duration
Diabetes Care February 2015, Vol.38, 529-537. doi:https://doi.org/10.2337/dc14-2073
Erratum
Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37:2149–2158
Michael Nauck; Ruth S. Weinstock; Guillermo E. Umpierrez; Bruno Guerci; Zachary Skrivanek; Zvonko Milicevic
Topics:
awards and prizes
,
diabetes mellitus, type 2
,
dulaglutide
,
sitagliptin
Diabetes Care February 2015, Vol.38, 538. doi:https://doi.org/10.2337/dc15-er03
Issues and Events
E-Letters: Observations
Effect of Bariatric Surgery Versus Intensive Medical Management on Diabetic Ophthalmic Outcomes
Rishi P. Singh; Richard Gans; Sangeeta R. Kashyap; Rumneek Bedi; Kathy Wolski; Stacy A. Brethauer; Steven E. Nissen; Deepak L. Bhatt; Philip Schauer
Topics:
bariatric surgery
,
eye
,
medical management
Diabetes Care February 2015, Vol.38, e32-e33. doi:https://doi.org/10.2337/dc14-2035
Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy
Topics:
continuous glucose monitoring
,
diabetes mellitus, type 1
,
fasting
,
subcutaneous insulin delivery
Diabetes Care February 2015, Vol.38, e34-e35. doi:https://doi.org/10.2337/dc14-1874
Retinal Thinning as a Marker of Disease Progression in Patients With Wolfram Syndrome
Agnieszka Zmyslowska; Wojciech Fendler; Anna Niwald; Malgorzata Ludwikowska-Pawlowska; Maciej Borowiec; Karolina Antosik; Agnieszka Szadkowska; Wojciech Mlynarski
Topics:
disease progression
,
retinal thinning
,
wolfram syndrome
Diabetes Care February 2015, Vol.38, e36-e37. doi:https://doi.org/10.2337/dc14-1898
Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment
Bess A. Marshall; Rebecca P. Green; Jennifer Wambach; Neil H. White; Maria S. Remedi; Colin G. Nichols
Topics:
disease remission
,
glyburide
,
neonatal diabetes mellitus
,
sulfonylurea compounds
,
insulin
Diabetes Care February 2015, Vol.38, e38-e39. doi:https://doi.org/10.2337/dc14-2124
E-Letters: Comments and Responses
Comment on Duran et al. Introduction of IADPSG Criteria for the Screening and Diagnosis of Gestational Diabetes Mellitus Results in Improved Pregnancy Outcomes at a Lower Cost in a Large Cohort of Pregnant Women: The St. Carlos Gestational Diabetes Study. Diabetes Care 2014;37:2442–2450
Topics:
gestational diabetes
,
international association of diabetes and pregnancy study groups
,
pregnancy
,
pregnancy outcome
,
screening
Diabetes Care February 2015, Vol.38, e40. doi:https://doi.org/10.2337/dc14-2414
Response to Comment on Duran et al. Introduction of IADPSG Criteria for the Screening and Diagnosis of Gestational Diabetes Mellitus Results in Improved Pregnancy Outcomes at a Lower Cost in a Large Cohort of Pregnant Women: The St. Carlos Gestational Diabetes Study. Diabetes Care 2014;37:2442–2450
Topics:
gestational diabetes
,
international association of diabetes and pregnancy study groups
,
pregnancy
,
pregnancy outcome
,
screening
Diabetes Care February 2015, Vol.38, e41-e42. doi:https://doi.org/10.2337/dc14-2589
Comment on Liu et al. Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes: A Nationwide, Multicenter Prospective Study (LADA China Study 3). Diabetes Care 2015;38:16–21
Topics:
antibodies
,
china
,
diabetes mellitus, type 2
,
disease progression
,
generalized anxiety disorder
Diabetes Care February 2015, Vol.38, e43. doi:https://doi.org/10.2337/dc14-2575
Response to Comment on Liu et al. Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes: A Nationwide, Multicenter Prospective Study (LADA China Study 3). Diabetes Care 2015;38:16–21
Topics:
antibodies
,
china
,
diabetes mellitus, type 2
,
disease progression
,
generalized anxiety disorder
Diabetes Care February 2015, Vol.38, e44. doi:https://doi.org/10.2337/dc14-2861
Response to Comment on O’Connor et al. Randomized Trial of Telephone Outreach to Improve Medication Adherence and Metabolic Control in Adults With Diabetes. Diabetes Care 2014;37:3317–3324
Topics:
medication adherence
,
telephone
Diabetes Care February 2015, Vol.38, e46. doi:https://doi.org/10.2337/dc14-2928
Response to Comment on Steck et al. Early Hyperglycemia Detected by Continuous Glucose Monitoring in Children at Risk for Type 1 Diabetes. Diabetes Care 2014;37:2031–2033
Andrea K. Steck; Fran Dong; Iman Taki; Michelle Hoffman; Georgeanna J. Klingensmith; Marian J. Rewers
Diabetes Care February 2015, Vol.38, e48. doi:https://doi.org/10.2337/dc14-2876
Comment on Tovote et al. Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial. Diabetes Care 2014;37:2427–2434
Diabetes Care February 2015, Vol.38, e49-e50. doi:https://doi.org/10.2337/dc14-2509